Syria vs Venezuela: Share of the population living with HIV receiving antiretroviral therapy
Syria
54.8%
in 2024
Venezuela
56.6%
in 2024
Syria rank
118th
Venezuela rank
116th
Share of the population living with HIV receiving antiretroviral therapy over time
- Syria
- Venezuela
How they compare
Venezuela currently reports 56.6% against 54.8% in Syria, a difference of 1.8%.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Venezuela ahead.
Syria ranks 118th and Venezuela ranks 116th of 149 countries.
Venezuela has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Syria | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 3.1% | 15.4% | 12.3% | Venezuela |
| 2010s | 22.2% | 44.6% | 22.4% | Venezuela |
| 2020s | 48.8% | 58.9% | 10.0% | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Syria or Venezuela?
- Venezuela, at 56.6% against 54.8% in Syria as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Syria and Venezuela?
- 1.8%, with Venezuela ahead.
- How many years of comparable data are there for Syria and Venezuela?
- 35 years are reported by both, from 1990 to 2024.
- How do Syria and Venezuela rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Syria ranks 118th and Venezuela ranks 116th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.